| NCT ID | NCT06702917 |
| Status | Recruiting |
| Phase | — |
| Sponsor | GE Healthcare |
| Condition | Coronary Computed Tomographic Angiography |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-09-10 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2025-09-10 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical data collection study is to collect raw CT scan data using a new GSI Cardiac mode on GE HealthCare's Revolution Apex CT system. Two groups of participants will be enrolled: A) Participants scheduled to undergo a Coronary CT Angiography (CCTA) as part of their standard of care B) Participants scheduled to undergo a cardiac catheterization or have a history of heart attack Participants in Group A will: -Have a standard of care CCTA immediately followed by a research GSI Cardiac scan Participants in Group B will: -Have a research CCTA immediately followed by a research GSI Cardiac scan Both groups will be in the study for approximately 1 day. There are no follow-up visits after the day of scan.
Eligibility Criteria
Inclusion Criteria: Subjects may be included in this study if they meet the following criteria: 1. Who are ≥18 years of age; 2. Able to sign and date the informed consent form; AND, 3. Cohort A: Undergoing a scheduled clinically indicated CCTA; OR, 4. Cohort B: Known history of myocardial infarction or undergoing a clinically indicated cardiac catheterization due to known pathology. Exclusion Criteria: Subjects may be excluded from participating in study if they meet any of the following criteria: 1. Who are pregnant or lactating; 2. Who were previously enrolled in this study; 3. Anyone with known or suspected allergy to iodinated contrast agents; 4. Anyone with known or suspected renal insufficiency as determined by site medical personnel; 5. Who are in need of urgent or emergent care; 6. Who have any conditions that, in the opinion of the PI or designee, would interfere with the evaluation of the results or constitute a health hazard for the subject; 7. Who are unwilling to have GEHC personnel present for the CT exam; AND, 8. Cohort A: Undergoing a scheduled clinically indicated CCTA for anatomy assessment (aberrant origin, etc.)
Contact & Investigator
Brian Thomsen
STUDY DIRECTOR
GE Healthcare
Frequently Asked Questions
Who can join the NCT06702917 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Coronary Computed Tomographic Angiography. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06702917 currently recruiting?
Yes, NCT06702917 is actively recruiting participants. Contact the research team at melissa.challman@gehealthcare.com for enrollment information.
Where is the NCT06702917 trial being conducted?
This trial is being conducted at Seattle, United States.
Who is sponsoring the NCT06702917 clinical trial?
NCT06702917 is sponsored by GE Healthcare. The principal investigator is Brian Thomsen at GE Healthcare. The trial plans to enroll 50 participants.